$87.08
At close: Mar 25, 8:00 PM EDT
$87.09
0.010.01%
After Hours: 7:47 PM EDT
As of Feb 28, 2025
SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI)
Ticker | Name | Share % | |
---|---|---|---|
NVAX | Novavax Inc | 3.06% | |
INSM | Insmed Inc | 2.61% | |
MRNA | Moderna Inc | 1.53% | |
NTRA | Natera Inc | 1.33% | |
DYN | Dyne Therapeutics Inc | 1.33% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 1.32% | |
PTCT | Ptc Therapeutics Inc | 1.29% | |
BPMC | Blueprint Medicines Corp | 1.27% | |
UTHR | United Therapeutics Corp | 1.26% | |
AMGN | Amgen Inc. | 2.88% | |
GILD | Gilead Sciences Inc | 3.18% | |
ABBV | Abbvie Inc. | 3.07% | |
BMRN | Biomarin Pharmaceutical Inc. | 2.73% | |
VRTX | Vertex Pharmaceuticals Inc | 2.62% | |
INCY | Incyte Corp. | 2.46% | |
ALNY | Alnylam Pharmaceuticals Inc. | 2.43% | |
HALO | Halozyme Therapeutics Inc | 2.37% | |
BIIB | Biogen Inc. | 2.28% |
The XBI ETF is currently trading at $87.08, which represents a 0.00% change. Over the past 52 weeks, the ETF has traded as high as $105.47 and as low as $81.14.
The expense ratio of XBI is 0.35%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for XBI is 5.67B. This represents the total market value of the assets managed by the ETF.
XBI follows a Small Cap Growth investment style.
The top holdings of XBI include: NVAX (3.06%), INSM (2.61%), MRNA (1.53%), NTRA (1.33%), DYN (1.33%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for XBI is currently not available.